NCT03001947 IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
| NCT ID | NCT03001947 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | IgA Nephropathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2012-11 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2012-11 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are registering all biopsy-proven primary IgA nephropathy (IgAN) patients at recruited hospitals and developing a IgAN database in China. Patients will be follow-up every one year, and both baseline and follow-up information will be entered into the registration system. All-cause and cardiovascular mortality and a composite renal outcome of doubling of serum creatinine and end stage renal failure (ESRD, defined as initiation of dialysis or kidney transplantation) of IgAN patients will be compared using the IgAN database.
Eligibility Criteria
Inclusion Criteria: 1. Biopsy-proven primary IgAN patients; 2. age ≥14 years old 3. Adequate biopsy sample containing ≥8 glomeruli. Exclusion Criteria: Secondary causes of mesangial IgA deposition, such as Henoch-Schonlein purpura nephritis, systemic lupus erythematosus, liver cirrhosis and et al; eGFR≤15ml/min/1.73m2 at biopsy.
Contact & Investigator
Xueqing Yu, M.D. & Ph.D
✉ yuxq@mail.sysu.edu.cnFrequently Asked Questions
Who can join the NCT03001947 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying IgA Nephropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03001947 currently recruiting?
Yes, NCT03001947 is actively recruiting participants. Contact the research team at yuxq@mail.sysu.edu.cn for enrollment information.
Where is the NCT03001947 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT03001947 clinical trial?
NCT03001947 is sponsored by Sun Yat-sen University. The trial plans to enroll 10,000 participants.